| John Cherry I, MD | |
|
3400 N Center Rd, Suite 400, Saginaw, MI 48603-7920 | |
| (989) 799-5600 | |
| Not Available |
| Full Name | John Cherry I |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 3400 N Center Rd, Saginaw, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134199896 | NPI | - | NPPES |
| 3454400 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 4301038313 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| John Cherry I, MD 3400 N Center Rd, Suite 400, Saginaw, MI 48603-7920 Ph: (989) 799-5600 | John Cherry I, MD 3400 N Center Rd, Suite 400, Saginaw, MI 48603-7920 Ph: (989) 799-5600 |
News Archive
LDR, a privately held company with innovative spinal implants for both non-fusion and fusion applications, reached the critical 24-month follow-up phase for the one-level IDE study on its second generation Mobi-C® cervical artificial disc. LDR is the first and currently the only company to have completed enrollment for a concurrent one-level and two-level cervical artificial disc replacement study. LDR completed 1-Level enrollment in October 2007 and 2-Level enrollment in March 2008.
Bioinsider has opened registration and a call for speaker proposals for its four-part virtual meeting series, Together as One COVID-19 Series.
An article published in Nature Medicine with the collaboration of the research group of Dr. Manel Esteller, director of the Epigenetics and Cancer Biology Program of the Bellvitge Biomedical Research Institute, ICREA Researcher and Professor of Genetics of the University of Barcelona, and Drs. Dave Monk and Isidre Ferrer, from the same center, shows that the inheritance of small changes in DNA alters the expression of the PM20D1 gene and is associated with an increased risk of developing Alzheimer's disease.
Cellectar, Inc., a privately held radiopharmaceutical company that designs and develops products to detect, treat and monitor human cancers, today announced that enrollment for its Phase I dosimetry trial for its lead drug candidate, (131)I-CLR1404 has been completed. Results of this trial will be used to set the starting dose in a follow-on Phase I dose escalation study planned for later this year. Institutions that participated in the trial include City of Hope, Duke University Medical Center, Georgetown University/Lombardi Cancer Center, and Johns Hopkins Hospital.
The new year promises new health care industry jobs around the country, but in some places, such as Indiana, a shortage of nursing instructors could lead to fewer trained nurses to fill those jobs.
› Verified 9 days ago
Dr. James A Fugazzi, M.D, Radiology Medicare: Accepting Medicare Assignments Practice Location: 5400 Mackinaw Rd, Saginaw, MI 48604 Phone: 989-583-5250 Fax: 989-583-5259 | |
Dr. Macksood Ahmad Aftab, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3400 N Center Rd, Suite 400, Saginaw, MI 48603 Phone: 989-753-9000 Fax: 989-753-4024 | |
Mark Anthony Zaki, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 5400 Mackinaw Rd, Saginaw, MI 48604 Phone: 989-583-5250 | |
Michael Logsdon, Radiology Medicare: Not Enrolled in Medicare Practice Location: 1500 Weiss St, Saginaw, MI 48602 Phone: 989-497-2500 | |
Dr. Ross Thomas Waterfield, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 3400 N Center Rd, Suite 400, Saginaw, MI 48603 Phone: 989-753-9000 Fax: 989-753-4024 | |
Nasser Omar Qadri, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3400 N Center Rd, Suite 400, Saginaw, MI 48603 Phone: 989-753-9000 Fax: 989-753-4024 |